In Australia, independent Members of Parliament are challenging the Government as to why off-label use of safe, low-cost medications such as ivermectin are being ignored, or even actively suppressed, despite numerous peer-reviewed clinical studies proving their effectiveness.
In this video, MP Craig Kelly discusses a recent meta-analysis of 24 randomised controlled clinical trials, published in the American Journal of Therapeutics, which demonstrates a 62% reduction in deaths from COVID-19 in patients treated with ivermectin, and evidence of 86% reduction in infections amongst those treated with ivermectin prophylaxis.